Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment
Go back to Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment| (NASDAQ: EDSA) | Delayed: 4.66 -0.06 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.72 | 52 Week High | $ | |||
| Open | $4.80 | 52 Week Low | $ | |||
| Day High | $4.90 | P/E | N/A | |||
| Day Low | $4.64 | EPS | $ | |||
| Volume | 40,237 | |||||
